Inexpensive retinal diagnostics via smartphone
Method is suitable for the detection of diabetes-related eye disease, shows study by the University of Bonn
Retinal damage due to diabetes is now considered the most common cause of blindness in working-age adults. In low- and middle-income countries, an eye examination via smartphone could help to detect changes at an early stage. This is shown by a new study carried out by scientists from the University of Bonn together with colleagues from Sankara Eye Hospital Bangalore (India). The results are published in the journal “Ophthalmology”.
One of the most dangerous long-term complications of diabetes is vascular damage. In the eye’s photosensitive layer, the retina, this also impacts the capillaries. This network of small vessels supplies the sensory cells with oxygen and nutrients. If it deteriorates, abnormal new vessels form instead and further harm the damaged retina. Left untreated, this often result in loss of vision and ultimately blindness.
“If such a retinopathy is recognized and treated in time, vision loss can often be prevented,” emphasizes Dr. Maximilian Wintergerst from the Department of Ophthalmology at the University Hospital Bonn. “An important aspect of therapy is better control of the diabetes; in addition, it is also possible to treat the undersupplied retina with laser light before further problems occur.” Laser treatment destroys the undersupplied retina so that it can no longer cause problems by releasing growth factors. These can otherwise cause the formation of abnormal vessels and fluid accumulation in the retina.
Screening alternative with potential
A lack of exercise and an increasingly high-calorie diet mean that diabetes is currently on the rise globally. It is estimated that 8 out of 10 people with diabetes worldwide live in developing and emerging countries, which often have a poorly resourced health system. Systematic retinal screening of diabetics is therefore usually not possible in these countries.
This could be overcome by using devices that were actually designed for a completely different purpose – smartphones. The increasingly affordable devices nowadays usually come with high-quality cameras. And these are surprisingly useful for diagnosing diseases of the retina. The current study conducted by Wintergerst together with colleagues from Bonn and Bangalore in southern India points in this direction.
In the study, the researchers compared four different approaches aimed at enabling ophthalmoscopy with a standard mid-range smartphone. Not all of them fulfilled this promise equally well. “The best result in our test was achieved by an adapter with an additional lens that is attached to the smartphone,” Wintergerst concludes. “It allowed almost 80 percent of eyes with any retinal changes to be detected, even in the early stages. Advanced damage could even be diagnosed 100 percent of the time.”
The scientists had trained optometrists (ophthalmic assistants) from the Sankara Eye Hospital in Bangalore for their study. On average, they needed one to two minutes per examination. This involved documenting changes in the retina by filming the back of the eye with a smartphone camera. The co-author of the study, Prof. Dr. Robert Finger from the Department of Ophthalmology at the University Hospital Bonn, considers these capabilities to be what makes the method so appealing: “This means that the examination can also be enabled by trained laypersons,” he says. “The images are then sent via the Internet to the ophthalmologist for diagnosis.”
“COVID-19 has further necessitated the need for us to explore methods of reducing patients visiting hospital. This modality is promising in increasing efficiency of screening for retinal changes in diabetics”, added co-author Dr. Mahesh P. Shanmugam, Head VitreoRetina & Ocular Oncology, Sankara Eye Foundation India.
Next step: artificial intelligence supports diagnostics
The researchers are currently developing an app in collaboration with their colleagues from the Sankara Eye Foundation in India. This app will make it possible to create an encrypted electronic patient file for each patient on the smartphones used for the examination. It not only stores the images, but also the findings of the doctor who ultimately reviewed them. Furthermore, the researchers are working on an automatic pre-evaluation of the images using artificial intelligence. In such methods, a software “learns” to recognize pathological changes independently on the basis of thousands of retinal images.
The researchers hope that their work will improve eye care in developing and emerging countries. The project is funded by the German Federal Ministry for Economic Cooperation and Development and the Else Kröner-Fresenius Foundation. Recently, it was also presented with the special award of the “bytes4diabetes Award” for innovative digital approaches in the fight against diabetes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Retinal diagnostics
- Eye2Gene and Heidelberg Engineering Announce Collaborative Partnership at ARVO 2024
Discover Eye2Gene and Heidelberg Engineering's groundbreaking partnership revolutionizing ophthalmic care with AI and imaging at ARVO 2024.
- ARVO 2024: AI may open new frontiers in vision research
Four poster presentations at the Association for Research in Vision and Ophthalmology’s (ARVO) 2024 Annual Meeting in Seattle, Washington, demonstrate the possibilities.
- Health-tech innovator Remidio achieves unprecedented scale in the US with its revolutionary retinal solutions
Remidio Inc., a health technology innovator developing cutting-edge technology to combat global blindness from Diabetic Retinopathy, Glaucoma, AMD, & Cataracts, is all set to achieve a significant ...
- DIAGNOS to Present Cutting-Edge AI Solutions for Retinal Health at ARVO 2024
Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health ...
- Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
Additional analysis of visual acuity loss, genotypic profiles, and retinal imaging data from a 24-month Phase 2 trial of Tinlarebant in adolescent Stargardt disease patients provides further support ...
Go deeper with Google Headlines on:
Retinal diagnostics
[google_news title=”” keyword=”retinal diagnostics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Diabetes-related eye disease
- Wayne State University researcher receives NIH grant to tackle diabetic eye infections
Fu-Shin Yu, Ph.D., professor of ophthalmology, visual and anatomical sciences in the Wayne State University School of Medicine, received an award from the National Eye Institute of the National ...
- EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Shares of EyePoint Pharmaceuticals dropped nearly 30% premarket on Monday after the company said its experimental eye disease treatment failed to meet ...
- Know The Stages of Type 2 Diabetes
Type 2 diabetes is a progressive condition which is characterised by insulin resistance and pancreatic beta cells fail to function. The stages of Type 2 diabetes can help in managing the disease more ...
- Diabetes: Know Symptoms, Causes, Types And Treatment
“Common symptoms of diabetes include feeling very thirsty, urinating a lot, being more tired than usual, losing weight without trying, and having blurry vision. If you notice these signs, see a doctor ...
- Wellness Wednesday: The importance of regular diabetes check ups
This early detection allows for prompt treatment, slowing the disease’s progression and improving your long term outlook. Next, let’s delve into diabetes-related eye damage. High blood sugar ...
Go deeper with Google Headlines on:
Diabetes-related eye disease
[google_news title=”” keyword=”diabetes-related eye disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]